| Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing T Wei, Q Cheng, YL Min, EN Olson, DJ Siegwart Nature communications 11 (1), 3232, 2020 | 272 | 2020 |
| Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing C Long, H Li, M Tiburcy, C Rodriguez-Caycedo, V Kyrychenko, H Zhou, ... Science advances 4 (1), eaap9004, 2018 | 217 | 2018 |
| CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells RBDENO Yi-Li Min, Hui Li, Cristina Rodriguez-Caycedo, Alex A. Mireault, Jian ... Science Advances 5, 2019 | 195 | 2019 |
| CRISPR correction of Duchenne muscular dystrophy YL Min, R Bassel-Duby, EN Olson Annual review of medicine 70, 239-255, 2019 | 139 | 2019 |
| Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system Y Zhang, H Li, YL Min, E Sanchez-Ortiz, J Huang, AA Mireault, JM Shelton, ... Science advances 6 (8), eaay6812, 2020 | 117 | 2020 |
| Mechanistic basis of neonatal heart regeneration revealed by transcriptome and histone modification profiling Z Wang, M Cui, AM Shah, W Ye, W Tan, YL Min, GA Botten, JM Shelton, ... Proceedings of the National Academy of Sciences 116 (37), 18455-18465, 2019 | 86 | 2019 |
| Structure–function analysis of myomaker domains required for myoblast fusion DP Millay, DG Gamage, ME Quinn, YL Min, Y Mitani, R Bassel-Duby, ... Proceedings of the National Academy of Sciences 113 (8), 2116-2121, 2016 | 70 | 2016 |
| Correction of three prominent mutations in mouse and human models of Duchenne muscular dystrophy by single-cut genome editing YL Min, F Chemello, H Li, C Rodriguez-Caycedo, E Sanchez-Ortiz, ... Molecular Therapy 28 (9), 2044-2055, 2020 | 44 | 2020 |
| The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells CD Liu, YL Chen, YL Min, B Zhao, CP Cheng, MS Kang, SJ Chiu, E Kieff, ... PLoS Pathogens 8 (12), e1003084, 2012 | 38 | 2012 |
| In vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse L Amoasii, H Li, Y Zhang, YL Min, E Sanchez-Ortiz, JM Shelton, C Long, ... Nature communications 10 (1), 4537, 2019 | 27 | 2019 |
| Identification of a multipotent Twist2-expressing cell population in the adult heart YL Min, P Jaichander, E Sanchez-Ortiz, S Bezprozvannaya, VS Malladi, ... Proceedings of the National Academy of Sciences 115 (36), E8430-E8439, 2018 | 17 | 2018 |
| Intercalation-mediated nucleic acid nanoparticles for siRNA delivery K Zhou, P Kos, Y Yan, H Xiong, YL Min, KA Kinghorn, JT Minnig, JB Miller, ... Chemical Communications 52 (82), 12155-12158, 2016 | 11 | 2016 |
| Long-term maintenance of dystrophin expression and resistance to injury of skeletal muscle in gene edited DMD mice DR Karri, Y Zhang, F Chemello, YL Min, J Huang, J Kim, PPA Mammen, ... Molecular Therapy-Nucleic Acids 28, 154-167, 2022 | 8 | 2022 |
| CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells. Sci Adv. 2019; 5 (3): eaav4324 YL Min, H Li, C Rodriguez-Caycedo, AA Mireault, J Huang, JM Shelton | 6 | |
| Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing. Sci Adv 4: eaap9004 C Long, H Li, M Tiburcy, C Rodriguez-Caycedo, V Kyrychenko, H Zhou, ... | 5 | 2018 |
| Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system. Sci Adv. 2020 Feb; 6 (8): eaay6812 Y Zhang, H Li, YL Min, E Sanchez-Ortiz, J Huang, AA Mireault English, 0 | 4 | |
| Generation and correction of a humanized mouse model with a deletion of dystrophin exon 44 MIN Yi-Li, R Bassel-Duby, E Olson US Patent 10,687,520, 2020 | 1 | 2020 |
| Correction of DMD Mutations in Human iPS-Derived Muscle Cells by Single-Cut CRISPR/Cas9-Based Gene Editing Z Al Tanoury, L Rao, R Ahmed, Y Ai, B Nixon, T Lee, P Tsai, CR Caycedo, ... MOLECULAR THERAPY 29 (4), 10-10, 2021 | | 2021 |
| Generation and correction of a humanized mouse model with a deletion of dystrophin exon 44 MIN Yi-Li, R Bassel-Duby, E Olson US Patent App. 15/930,781, 2020 | | 2020 |
| Correction of Hot Spot Mutations in Duchenne Muscular Dystrophy by CRISPR/Cas9 Gene Editing YL Min | | 2018 |
